4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.? 4D has developed a proprietary platform, MicroRx®, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.
$12.59 -0.14 (-1.10%)
As of 04/13/2021 16:00:00 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.